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41 The cys-loop ligand-gated ion channels, including the glutamate-gated chloride 
42 channel (GluCl) and GABA-gated chloride channel (Rdl) are important targets for drugs 
43 and pesticides. The macrocyclic lactone abamectin primarily targets GluCl and is 
44 commonly used to control the spider mite Tetranychus urticae, an economically 
45 important crop pest. However, abamectin resistance has been reported for multiple T. 
46 urticae populations worldwide, and in several cases was associated with the mutations 
47 G314D in GluCl1 and G326E in GluCl3. Recently, an additional I321T mutation in 
48 GluCl3 was identified in several abamectin resistant T. urticae field populations. Here, 
49 we aim to functionally validate this mutation and determine its phenotypic strength. 
50
51 RESULTS
52 The GluCl3 I321T mutation was introgressed into a T. urticae susceptible background 
53 by marker-assisted backcrossing, revealing contrasting results in phenotypic strength, 
54 ranging from almost none to 50-fold. Next, we used CRISPR-Cas9 to introduce I321T, 
55 G314D and G326E in the orthologous Drosophila GluCl. Genome modified flies 
56 expressing GluCl I321T were threefold less susceptible to abamectin, while CRISPRed 
57 G314D and G326E flies were lethal. Last, functional analysis in Xenopus oocytes 
58 revealed that the I321T mutation might reduce GluCl3 sensitivity to abamectin, but also 
59 that all three T. urticae Rdls are affected by abamectin at high concentrations.
60
61 CONCLUSION
62 Three different techniques were used to characterize the role of I321T in GluCl3 in 
63 abamectin resistance and, combining all results, our analysis suggests that the I321T 
64 mutation has a complex role in abamectin resistance. Given the reported subtle effect, 
65 additional synergistic factors in resistance warrant more investigation.
66
67 Keywords: avermectin, ivermectin, arthropoda, GluCl, Rdl, two-electrode voltage-
68 clamp electrophysiology


































































70 Macrocyclic lactones such as avermectins and milbemycins are natural fermentation 
71 products of Streptomyces bacteria. They exhibit strong insecticidal, nematicidal, and 
72 acaricidal activity with low toxicity in mammals and have been widely used in pest 
73 control and as anthelmintics in animal and human health for several decades.1–5 
74 Macrocyclic lactones are neurotoxins known to act on cys-loop ligand-gated ion 
75 channels (LGICs). These channels contain five homologous subunits, where each 
76 subunit consists of a large N-terminal extracellular domain, four hydrophobic alpha-
77 helical transmembrane segments (TMs), an intracellular loop between TM3 and TM4 
78 and a short extracellular C terminus to form a central ion channel lining (Fig. 1a).6–9 In 
79 invertebrates, the glutamate-gated chloride channel (GluCl), GABA-gated chloride 
80 channel (GABACl, also known as Resistance to dieldrin (Rdl)), the histamine-gated 
81 chloride channel (HisCl) and the pH-sensitive chloride channel (pHCl) belong, amongst 
82 others, to the cys-loop LGIC family.2,10–14 In Caenorhabditis elegans six GluCl and one 
83 Rdl gene have been identified,7,8,15,16 while most insects, except Lepidoptera and 
84 aphids, only have a single GluCl and Rdl gene. Genome sequencing of the spider mite 
85 Tetranychus urticae and the honeybee mite Varroa destructor, revealed the presence 
86 of five GluCl and three Rdl genes in T. urticae, while three Rdl genes have been found 
87 in V. destructor.14,17–21 The GluCl has an important role in the nervous system, 
88 including modulation of locomotion, regulation of feeding and mediation of sensory 
89 inputs and is the primary target of macrocyclic lactones, while Rdl is considered as a 
90 secondary target of these compounds.15,22–26 Fuse et al., for example, showed that the 
91 EC50 of ivermectin, an avermectin, was more than 150-fold larger for Musca domestica 
92 Rdl than for GluCl.26 Of peculiar note, cys-loop channels, sensitive to ivermectin, 
93 consisting of both GluCl and Rdl subunits have previously been reported.12,27,28 
94 The spider mite T. urticae is a highly polyphagous pest and develops resistance 
95 very rapidly.29,30 A frequently used compound to control T. urticae is abamectin, a 
96 mixture of avermectins containing a minimum of 80% avermectin B1a and maximum 20% 
97 avermectin B1b. Due to its extensive application for decades, increasing field abamectin 
98 resistance in T. urticae has been reported.31–36 Backcrossing experiments and F2 
99 screen showed that two mutations, G314D in GluCl1 and G326E in GluCl3, were 
100 associated with abamectin resistance in T. urticae.14,37 Based on the crystal structure 
101 of the C. elegans GluClα-subunit and its binding-mode to ivermectin, a residue in the 

































































102 third transmembrane region (TM3), equivalent to the position of the above two 
103 mutations, was likely involved in the formation of the allosteric site and located closest 
104 to ivermectin.7 In addition, functional validation using two electrode voltage-clamp 
105 electrophysiology and Xenopus oocytes also revealed that a G326E substitution in T. 
106 urticae GluCl3 completely abolished the agonistic activity of abamectin.38 Further, an 
107 identical substitution at an equivalent position in Plutella xylostella GluCl reduced the 
108 sensitivity to abamectin by about 500-fold,39 while a G329D substitution (corresponding 
109 to G314D in T. urticae GluCl1) in Haemonchus contortus GluCl, abolished binding with 
110 the macrocyclic lactone milbemycin A4.40 
111 Recently, a target-site (GluCl) screening of 32 European field T. urticae strains, 
112 revealed the presence of a potential new target-site mutation, I321T in GluCl3, in four 
113 abamectin resistant strains.36 This mutation was also found in another abamectin 
114 resistant strain from Peloponnese, Greece in a recently published paper of 
115 Papapostolou et al. 2020.41 This mutation is adjacent to A309V, a previously reported 
116 abamectin resistance associated mutation in P. xylostella.39 In addition, two other 
117 mutations V327G (adjacent to the important G326 residue) and L329F were also found 
118 in GluCl3 of a strain exhibiting an around 500-fold resistance ratio (RR). L329 
119 corresponds to M345 of C. elegans GluClα, a residue predicted to be involved in 
120 ivermectin binding;7 while two substitutions at a position equivalent to L329F (L315F 
121 and L319F in GluCl of M. domestica and Bombyx mori, respectively) also showed 
122 reduced sensitivity to ivermectin.42,43 However, none of these recently identified 
123 mutations (I321T, V327G and L329F) have been functionally validated in T. urticae. 
124 Characterizing the properties of these mutations could help in understanding the 
125 macrocyclic lactone resistance mechanisms in T. urticae and, in the long term, might 
126 aid in designing effective pest management strategies. In this study, the main aim is to 
127 characterize the I321T mutation in GluCl3. First, we performed electrophysiological 
128 analyses to clarify the effect of abamectin on GluCl3 wild-type, I321T GluCl3 and Rdls 
129 in T. urticae. Next, marker-assisted back-crossing was used to introduce the mutation 
130 into a T. urticae line with a susceptible genetic background, and the relative 
131 contribution of the mutation to abamectin resistance was assessed. Finally, CRISPR-
132 Cas9 technology was used to introduce the I321T mutation in the Drosophila GluCl 
133 homologue, and the effect of I321T on abamectin resistance was compared against 
134 the nos.Cas9 stock and G314D and G326E flies.

































































135 2 MATERIALS AND METHODS
136 2.1 Mite strains
137 The abamectin susceptible strain SR6 was collected from tomato plants in Italy in 2017. 
138 This strain was inbred by six rounds of mother-son mating as previously described in 
139 Bryon et al. 2017 and screened for the presence of mutations in GluCl1/2/3/4/5 TM3 
140 and Rdl1/2/3 TM2/TM3 regions (see 2.2).44 The abamectin resistant strain IT6 has 
141 been previously described and of all five GluCl genes only GluCl3 carried an I321T 
142 mutation,36 while the TM2/TM3 region of Rdl1/2/3 was screened in this study (see 2.2.) 
143 The abamectin resistant strain TR2 (corresponding to sample number 2 in İnak et al. 
144 2019) has been previously described and lacks the previously documented abamectin 
145 resistance mutations, G314D in GluCl1 and G326E in GluCl3.45 The TM3 region of 
146 GluCl2/4/5, I321T mutation in GluCl3 and TM2/TM3 region Rdl1/2/3 of TR2 were 
147 screened in this study (see 2.2). In our previous study, the strains IT1, IT5 and ES1 
148 were screened for the presence of mutations in TM3 of GluCl1/2/3/4/5 36 while the 
149 TM2/TM3 regions of Rdl1/2/3 of these strains were screened in this study. Furthermore, 
150 all GluCl and Rdl genes from MR-VL from Belgium46, were also screened in this study. 
151 Detailed information of all strains can be found in Table S1. All T. urticae strains were 
152 maintained on non-sprayed kidney bean leaves (Phaseolus vulgaris L. cv. “Prelude”) 
153 under laboratory conditions (25±1°C, 60% relative humidity, and 16:8 hr light: dark 
154 photoperiod).
155 2.2 Survey of genotypes in GluCl TM3 and Rdl TM2/TM3 regions 
156 Genomic DNA (gDNA) of strains IT1, IT5, IT6, ES1, MR-VL and SR6 was extracted 
157 from approximately 200 T. urticae female adults as described earlier by Van Leeuwen 
158 et al. (2008). gDNA of the TR2 strain was extracted from approximately 100 adult 
159 female mites with the Qiagen DNeasy Blood & Tissue Kit following the manufacturer’s 
160 instructions. Quality and quantity of DNA were checked via a spectrophotometer 
161 (Thermo Scientific NanoDrop 2000 or a DeNovix DS-11 (DeNovix, Willmington, DE, 
162 USA)). PCR amplification of the TM3 regions from five GluCl genes and TM2/TM3 
163 fragments from three Rdl genes was performed as described by Dermauw et al..14 
164 Primers used for PCR are listed in Table S3. PCR-products were purified using E.Z.N.A. 
165 Cycle Pure Kit (Omega Bio-Tek) and were sequenced (LGC genomics, Germany). All 
166 sequenced data was analysed using BioEdit version 7.0.5.2..47

































































167 2.3 Toxicity bioassays
168 Toxicity bioassays were carried out with commercially formulated abamectin (Vertimec 
169 18 g a.i./L EC or Agrimec 18 g a.i./L EC). At least five concentrations (causing between 
170 20 and 80% mortality) were tested in four replicates and blank controls were sprayed 
171 with deionised water only. For each replicate, about 20-30 young adult female mites 
172 were transferred to 9-cm2 bean leaf disks and sprayed with serial pesticide dilutions at 
173 1 bar pressure. For IT6 and congenic lines (2.4), a Cornelis spray tower was used for 
174 spraying leaf disks and 0.8 mL of pesticide dilution was applied to obtain a 1.5 ± 0.05 
175 mg aqueous acaricide deposit cm-2.45,46,48 For TR2 and congenic lines (2.4), a Potter 
176 spray tower (Burkard Scientific Ltd, Uxbridge, UK) was used for spraying and 2 mL of 
177 acaricide dilution was applied to obtain a 1.95 ± 0.05 mg aqueous acaricide deposit 
178 cm-2. LC50 and LC90 values and their 95% confidence intervals (CIs) were determined 
179 with PoloPlus (LeOra Software, Berkeley, CA, USA, 2006).49 Resistance ratios (RRs) 
180 were considered significantly different when their 95% CI did not include the value 1.50 
181 2.4 Backcrossing experiments
182 2.4.1 Establishment of congenic lines
183 To assess the resistance levels associated with the I321T mutation, we used a marker 
184 assisted backcrossing approach to produce near-isogenic sister lines as previously 
185 outlined in Riga et al. 2017.51 Briefly, a haploid male of a resistant strain (IT6= BC1 or 
186 TR2= BC2) was crossed with a virgin female of the susceptible strain SR6, in three 
187 and four replicates respectively. The resulting heterozygous virgin females of each 
188 replicate cross were backcrossed to susceptible males of SR6 and heterozygote 
189 genotypes (I321/T321) were identified by PCR and sequencing as described in section 
190 2.4.2. This process was repeated for seven generations. In the last generation, 
191 backcrossed heterozygous virgin females were crossed with their first-born sons, 
192 representing either the I321 or T321 genotype respectively, and resulting in congenic 
193 homozygous lines (with either the I321/I321 or T321/T321 genotype).
194 2.4.2 Single mite DNA extraction and genotyping
195 DNA from individual adult females was extracted using the Qiagen DNeasy Blood & 
196 Tissue Kit following the manufacturer instructions, or by homogenization in 20 μL STE 
197 buffer (100 mM NaCl, 10 mM Tris- HCl and 1 mM EDTA) with 1 mg ml−1 proteinase K 
198 (Sigma-Aldrich, Overijse, Belgium) and incubated for 30 min at 37 °C and 5 min at 
199 95 °C.51 The primers used to amplify the TM3 of GluCl3 were as follows: 5'-3' 

































































200 CCGGGTCAGTCTTGGTGTTA and 3'- 5' CACCACCAAGAACCTGTTGA.14 Then 
201 standard PCR was conducted with single mite DNA. PCR products were purified and 
202 sequenced (LGC genomics, Germany and Macrogen Inc., Seoul, Korea). All 
203 sequenced data was analysed using BioEdit version 7.0.5.2.47 
204 2.4.3 Toxicity bioassays of congenic lines 
205 Toxicity bioassays with abamectin were carried out as described in 2.3. 
206 2.5 CRISPR-Cas9 genome editing in Drosophila
207 2.5.1 Drosophila stocks
208 Genome modification of Drosophila was performed in the strain y1 M{nos-Cas9.P} ZH-
209 2A w*,52 in which Cas9 is expressed under the control of the nos promoting element 
210 (strain #54591 at the Bloomington Drosophila stock center, hereafter referred to as 
211 nos.Cas9). We also used a balancer stock for the third chromosome (yw; TM3 Sb e / 
212 TM6B Tb Hu e), hereafter referred to as TM3/TM6B. Flies were cultured under 
213 laboratory conditions (25 °C, 60-70% relative humidity, and 12:12 hr light: dark 
214 photoperiod) and fed on a standard fly diet. 
215 2.5.2 Drosophila DNA purification and amplification
216 DNA was purified from Drosophila by DNAzol® (MRC) according to manufacturer 
217 instructions. PCR amplification with relevant primer pairs (Table S3) was performed 
218 with Taq DNA Polymerase (MINOtech BIOTECHNOLOGY) and the conditions used 
219 were 94 °C for 2 min, followed by 35 cycles of denaturation at 94°C for 45 sec, 
220 annealing at 57 °C (generic primers) or 51 °C (specific primers) for 30 sec, and 
221 extension at 72 °C for 30 sec followed by a final extension step at 72 °C for 5 min.
222 2.5.3 Genomic engineering strategy
223 An ad hoc CRISPR-Cas9 genomic engineering strategy was designed in order to 
224 generate the mutations of interest (GluCl1 G314D, GluCl3 G326E and GluCl3 I321T, 
225 T. urticae numbering) at the GluCl gene (CG7535) of D. melanogaster (Fig. S1). 
226 In order to identify possible variations from the published genome sequence, 
227 two sets of primers pairs were used (GluExFw/GluExRv and GluInFw/GluInRv, Table 
228 S3) and a nos.Cas9 DNA template to amplify and sequence a 1771 bp DNA fragment 
229 corresponding to the genomic region 3R: 19,763,419-19,765,189 (BDGP6.28 genome 
230 assembly) encompassing exons 8 and 9 of GluCl (Fig. S1). Potential CRISPR targets 
231 in the region of interest were identified using the online tool Optimal Target Finder53 

































































232 (http://tools.flycrispr.molbio.wisc.edu/targetFinder/) and a target with no predicted off-
233 target hits was selected. 
234 A relevant sgRNA expressing plasmid was generated using vector pU6-BbsI 
235 chiRNA54 by sub cloning a double stranded DNA oligo (generated by annealing sense 
236 and antisense sgRNA oligos (Table S3). To facilitate Homologous Directed Repair 
237 (HDR), three donor plasmids were synthesized de novo (donorI321T, donorG314D 
238 and donor G326E (Genscript, NJ, USA)) containing two ~800 bp homology arms 
239 flanking the CRISPR target. The donor sequences correspond to the genomic region 
240 3R: 19,763,457-19,765,164 and contain the non-synonymous substitution that 
241 generates the relevant mutations as well as certain synonymous mutations 
242 incorporated for diagnostic purposes or to avoid cleavage of the donor plasmid by the 
243 CRISPR/Cas9 machinery. Plasmid donorG314D contained the non-synonymous 
244 GGCGAC substitution (leading to the G314D mutation), as well as synonymous 
245 mutations to abolish an existing ClaI restriction site and introduce a new MluI restriction 
246 site (Fig. S2a). Similarly, plasmid donorG326E contained at the same site the non-
247 synonymous GGCGAG substitutions (leading to the G326E mutation), as well as 
248 synonymous mutations to abolish an existing XhoI restriction site and introduce a new 
249 AccI restriction site (Fig. S2b), while plasmid donorI321T contained the non-
250 synonymous ATCACC substitution (leading to the I321T mutation and abolishment 
251 of ClaI) as well as certain synonymous mutations to introduce MluI and inhibit 
252 recognition and cleavage of the plasmid by CRISPR/Cas9 (Fig. S2c). Note that the 
253 GD or GE mutations occur at the same position (G312 in Drosophila GluCl) for 
254 donorG314D and donorG326E, respectively. 
255 2.5.4 Generation and screening of genome modified flies
256 Preblastoderm nos.Cas9 embryos were injected with a plasmid mixture containing 75 
257 ng/ μL of sgRNA plasmid and 100 ng/ μL of donor plasmid in injection buffer (2 mM 
258 Sodium phosphate pH 6.8-7.8, 100 mM KCl). Injected G0 adults were back-crossed to 
259 nos. Cas9 and G1 progeny was initially screened en masse to identify crosses that had 
260 produced G1 flies that underwent HDR events (Fig. S3a). Screening was performed by 
261 DNA extraction from batches of ~30 individuals per vial, digesting ~2 μg of total DNA 
262 with ClaI (for G314D and I321T) or XhoI (for G326E) in order to preferentially digest 
263 wild-type alleles but not the genome modified alleles that contain the donor sequence 
264 where the corresponding site is absent, and using ~30 ng of the digested DNA as 

































































265 template for amplification. Screening was performed either with a “generic” primer pair 
266 yielding a 489 bp product that was further digested with MluI (for G314D and I321T) or 
267 AccI (for G326E) that were introduced into the genome modified allele, or in the case 
268 of I321T with a “specific” primer combination (Dmel_GluCl_generic_F / 
269 Dmel_GluCl_specific_R, Table S3) that generates a diagnostic fragment (429 bp) in 
270 the presence of the modified allele. 
271 In case the presence of genome modified alleles was indicated in the pool, 
272 individual G1 flies from the same original cross were outcrossed with nos.Cas9 flies 
273 and after generating progeny (G2), they were screened individually to identify crosses 
274 bearing genome modified alleles. Several lines originating from positive G1 flies were 
275 established, and individual G2 flies (expected to be heterozygous for the mutant allele 
276 at a 50% ratio) were balanced against a TM3 / TM6B balancer strain and then 
277 individually screened (Fig. S3b) to select crosses generating G3 progeny containing 
278 the genome modified allele against the balancer chromosome. Then, single balanced 
279 G3 flies were back-crossed with the same balancer fly stock and following a final 
280 molecular screening, adults with Stubble phenotype from two positive lines 
281 (heterozygous for the mutation) were collected and crossed among themselves to 
282 generate two homozygous strains bearing the I321T mutation. The established lines 
283 were sequence verified (Fig. S3c). Sequencing reactions were performed at CeMIA 
284 sequencing facility (CEMIA, S.A., Greece).
285 2.5.5 Bioassays
286 Abamectin was used for toxicity bioassays as a commercial insecticide formulation 
287 (Vertimec 18 g a.i./L EC). Bioassays were performed as previously described.55 Briefly, 
288 2nd instar larvae were collected and transferred in batches of 20 into new vials 
289 containing fly food supplemented with different insecticide concentrations. Total 
290 development time was monitored for a period of 10-15 days for each applied insecticide 
291 concentration, and pupation efficiency was used as a proxy for survival. Five to six 
292 insecticide concentrations that cause 5-95% mortality (when applicable) were tested 
293 in triplicates, together with relevant negative (no insecticide) controls for I321T and the 
294 wild-type (nos.Cas9) strains.
295 2.5.6 Statistical analyses
296 Observed mortality for each insecticide concentration was corrected for control (no 
297 insecticide) mortality using Abbott’s formula.56 The LC50 values and 95% confidence 

































































298 intervals (CIs) were calculated via probit analysis using PoloPlus (LeOra Software, 
299 Berkeley, California), resistance ratios (RRs) were considered significantly different 
300 when the 95% CI of the RRs did not include the value 1.50 
301 2.6 Two-electrode voltage-clamp electrophysiology
302 2.6.1 Vector construction and cRNA synthesis
303 The TuGluCl3 I321T plasmid was generated by GenScript (Piscataway, New Jersey, 
304 USA) using site-directed mutagenesis and the TuGluCl3 WT plasmid, previously 
305 described in Mermans et al 2017, as template. The TuRdl# constructs were in silico 
306 generated in an identical way as TuGluCl3 WT constructs38 except that the T. urticae 
307 GluCl3 coding sequence was replaced by either T. urticae Rdl1 (GenBank acc. 
308 AB567686.1, TuRdl1), Rdl2 (tetur36g00580, accessible at ORCAE57 
309 ((https://bioinformatics.psb.ugent.be/orcae/overview/Tetur)), TuRdl2) and Rdl3 
310 (tetur36g00590 accessible at ORCAE, TuRdl3) (also see File S1). All T. urticae Rdl 
311 coding sequences were codon optimized for Xenopus expression using the 
312 OptimumGene™-Codon Optimization software of GenScript. Next, TuRdl# constructs 
313 were synthesized de novo and ligated into a pUC57 plasmid by Genscript. After 
314 transformation into DH5α competent Escherichia coli (Invitrogen, Carlsbad, CA, USA) 
315 GluCl and Rdl plasmids were purified using the E.Z.N.A.® Plasmid DNA Mini Kit I 
316 (Qiagen, Germantown, MD, USA). The plasmids were linearized with NotI-HF 
317 restriction endonuclease (New England BioLabs Inc., Ipswich, MA, USA) followed by 
318 extraction using the phenol and chloroform method with ethanol precipitation 58. 
319 Capped mRNAs were generated using the mMESSAGEmMACHINE T7 transcription 
320 kit (Thermo Fischer Scientific, Waltham, MA, USA) according to manufacturer 
321 instructions. Synthesized cRNAs were purified with a RNeasy MinElute Cleanup Kit 
322 (Qiagen, Germantown, MD, USA), dissolved in nuclease-free water and stored at -
323 80 °C until use.
324 2.6.2 Oocyte injection and two-electrode voltage clamp electrophysiology
325 Defolliculated, stage V–VI X. laevis oocytes were acquired form Ecocyte Bioscience 
326 (Castrop-Rauxel, Germany) in Tris-buffered Barth's solution (Ecocyte Bioscience). 
327 Oocytes were microinjected using a Nanoject III Programmable Nanoliter Injector 
328 (Drummond Scientific Co., Broomali, PA, USA) with 75 nL of cRNA solution (25–50 ng/ 
329 μL) and incubated at 18 °C in sterile Barth’s solution. Recordings were made 1–4 days 
330 post-cRNA injection. Two-electrode voltage-clamp (TEVC) measurements were 

































































331 conducted with the fully automated Roboocyte2 (Multi Channel Systems MCS GmbH, 
332 Reutlingen, Germany); oocytes were held in a standard 96-well microtitre plate and 
333 impaled with two glass microelectrodes filled with 0.1 M KCl 1.5 M potassium acetate 
334 solution. Oocyte membrane potentials were fixed at -60mV throughout the experiment.
335 2.6.3 Actions of L-glutamic acid and abamectin on wild type and I321T GluCl3
336 Test solutions of L-glutamic acid monosodium salt monohydrate (CAS number 6106-
337 04-3; Sigma–Aldrich) and abamectin (CAS number 71751-41-2, more than 80% 
338 avermectin B1a and less than 20% avermectin B1b; Sigma–Aldrich) were freshly 
339 prepared from stock solutions made with dimethyl sulfoxide (DMSO) and diluted with 
340 Normal Frog Ringer (NFR) solution (Ecocyte Bioscience). DMSO concentrations for 
341 test solutions did not exceed 1%. Dose-response curves to the natural agonist and 
342 compounds were obtained by sequential applications for 30 s of increasing 
343 concentrations with a 90s recorded wash-out (NFR) between applications for the 
344 channel to recover from desensitization. Abamectin application was proceeded by L-
345 glutamic acid (at EC50 concentration) to normalize the response and to validate GluCl 
346 expression. An extra two min non-recorded wash-out was maintained between 
347 abamectin applications to further allow the current to return to baseline as 
348 desensitization from abamectin is slow. Next, abamectin was co-applied with L-
349 glutamic acid for 30 sec to both wild type and I321T injected oocytes to test abamectin 
350 potentiation of glutamate-induced currents. Responses to L-glutamic acid applications 
351 were normalized (I% = (I/ Imax) × 100) and graphed as means ± SEM (standard error 
352 of the mean) using at least 6 oocytes. TEVC recordings were analyzed using the 
353 Roboocyte 2+ V. 1.4.3. software (Multi Channel Systems MCS GmbH), EC50, pEC50 
354 values and Hill coefficients were calculated by fitting a four-parameter logistic curve 
355 (Hill equation) on response data using SigmaPlot software 13.0 (Systat Software, San 
356 Jose, CA, USA).
357 2.6.4 Actions of γ-aminobutyric acid and abamectin on wild type T. urticae Rdls
358 The activity of γ-aminobutyric acid (GABA; CAS number 56-12-2; Sigma–Aldrich) and 
359 abamectin on three T. urticae Rdls (Rdl1, Rdl2 or Rdl3) channels was examined as 
360 described above, with a prolonged abamectin application of 3 min. To assess the 
361 antagonistic effect of abamectin, oocytes were tested based on Rufener et al. 2017.59 
362 Oocytes were first exposed to GABA (EC5, EC50 or EC90 concentration) 4 times for 30 
363 s every 1.5 min at the beginning of the experiment to test for Rdl expression and to 

































































364 stabilize the response. Subsequently, oocytes were pre-exposed for 75 s to abamectin 
365 (1 nM-10 µM) followed by 30 s of co-applied GABA (EC50) and abamectin. Both 
366 compounds were washed out (non-recorded) for 3.5 min before increasing to the next 
367 concentration.
368 2.7 Figure editing 
369 CorelDRAW Home & Student ×7, SigmaPlot 13.0 and GraphPad Prism 5 software 
370 were used to process and edit the figures.
371 3 RESULTS
372 3.1 Genotyping of GluCl TM3 and Rdl TM2/TM3 regions in T. urticae field 
373 isolates
374 During a target-site (GluCl) screening of 32 European field T. urticae strains, we 
375 previously detected an I321T (ATT->ACT) mutation in GluCl3 in four abamectin 
376 resistant strains from Spain and Italy (Fig. S4 and Table S2).36 To further explore the 
377 occurrence of this mutation in Europe, a number of additional strains were tested which 
378 revealed the occurrence of the mutation in a abamectin resistant field strain from 
379 Turkey (TR2) and a multi-acaricide resistant strain from Belgium, MR-VL46 (Fig. S4 and 
380 Table S2). The mutation I321T was fixed in MR-VL but was segregating in TR2. PCR 
381 and sequencing confirmed the absence of TM3 mutations in all five GluCl genes in the 
382 susceptible strain SR6. As Rdl is considered as a potential secondary target of 
383 macrocyclic lactones,12,27,28 the TM2/TM3 fragments of three Rdl genes were also 
384 screened for all seven strains in this study but no mutations were identified in any of 
385 the tested strains. 
386 3.2 Abamectin resistance levels
387 The results of the toxicity tests are listed in Table S2. The strains IT1, IT5, IT6 and TR2 
388 with only the I321T mutation in TM3 region of GluCl3, were all resistant to abamectin 
389 with LC50s over 10 mg a.i./L and resistance ratios (RRs) ranging from 46.63- to 104.0-
390 fold compared to the susceptible strain SR6. The ES1 strain with three segregating 
391 mutations I321T/V327G/L329F in GluCl3 showed the highest levels of abamectin 
392 resistance (78.59 mg a.i. /L) with RRs reaching 327.5 -fold. Another strain MR-VL (with 
393 the I321T mutation in TM3 region of GluCl3) exhibited low levels of abamectin 
394 resistance (1.79 mg a.i. /L) with only 7.46-fold RR.

































































395 3.3 Backcrossing experiments
396 3.3.1 Establishment of congenic lines
397 Two backcross experiments (BC1 and BC2) were carried out between a parental 
398 resistant strain, fixed for the I321T GluCl3 mutation, and a susceptible strain, lacking 
399 the mutation (BC1: ♀ SR6 x ♂ TR2 and BC2: ♀ SR6 x ♂ IT6). After seven rounds of 
400 backcrossing and the final cross between heterozygous backcrossed females and their 
401 sons, two lines that were homozygous for the I321T mutation (TRA_R1, TRA_R2; 
402 T321/T321 genotype), and two congenic control lines, lacking the mutation (TRA_C1, 
403 TRA_C2; I321/I321 genotype), were obtained for BC1. For the BC2 experiment, three 
404 lines with the T321/T321 genotype (ITA_R1, ITA_R2, ITA_R3) and three susceptible 
405 control lines with the I321/I321 genotype (ITA_C1, ITA_C2, ITA_C3) were obtained. 
406 3.3.2 Toxicity assays of congenic lines
407 Before the start of the backcross experiments, abamectin was tested on all parental 
408 strains (SR6, TR2 and IT6). The abamectin RR of TR2 and IT6 was 82 and 105 -fold 
409 respectively (Table 1). In BC1, the lines with the T321/T321 genotype showed 
410 resistance to abamectin with RRs up to 50-fold (Table 1) while for BC2, RRs of the 
411 lines with the T321/T321 genotype were less than two-fold and not significantly 
412 different from 1 (Table 1).
413 3.4 CRISPR-Cas9 genome editing in Drosophila
414 3.4.1 Introduction of I321T in Drosophila GluCl
415 Several genome-edited fly lines bearing an I321T (T. urticae GluCl3 numbering) 
416 mutation in the GluCl gene were established. We confirmed the presence of HDR-
417 derived alleles in five out of eighteen different G0 lines that gave G1 progeny (Fig. S3). 
418 Two phenotypically homozygous lines were sequence verified, bearing the correct 
419 mutation (Fig. S3c) at the Drosophila GluCl gene. One of these was used for 
420 downstream toxicity bioassays. Feeding toxicity bioassays with Drosophila larvae 
421 against abamectin were carried out using nos.Cas9 flies as controls. Drosophila larvae 
422 were in continuous contact with the insecticide containing food. Since the fly larvae are 
423 not readily visible in the food, we considered pupation efficiency as a measurable proxy 
424 of eventual survival. The results (Table 2) indicate that flies bearing the I321T mutation 
425 are more resistant to abamectin than the control (nos.Cas9) flies carrying the wild-type 
426 Drosophila GluCl allelic combination. As shown in Table 2, LC50 value for nos.Cas9 is 

































































427 0.018 mg/L (95% Cl: 0.014 - 0.020), while for I321T flies the corresponding value is 
428 0.048 mg/L (95% Cl: 0.039 - 0.055), which translates to a resistance ratio (RR) of 2.7 
429 folds. It must be noted, however, that I321T flies apparently exhibited slower 
430 development when exposed to abamectin, even at the lowest concentration (c. 15 days 
431 from egg to adult at 25°C compared to 10-11 days for the nos.Cas9 background strain)
432 3.4.2 Introduction of G314D or G326E in Drosophila GluCl
433 Several genome-edited fly lines bearing the G314D of G326E mutation (T. urticae 
434 GluCl1 and GluCl3 numbering, respectively) in the GluCl gene were generated. The 
435 presence of HDR-derived alleles in ten out of thirty-nine different G0 lines that gave G1 
436 progeny for G314D and seven out of seventeen G0 lines for G326E was confirmed. 
437 Several independent lines were established and balanced, but at the final crossing 
438 step virtually no phenotypically homozygous flies could be identified, indicating an 
439 associated lethality in both genome-modified alleles. A very small number of “escaper” 
440 flies without the balancer-associated marker Stubble was eventually observed after 
441 several generations of inter-crosses between heterozygotes derived from the same or 
442 different G0 lines (three flies in total among several thousands of screened progeny). 
443 These flies were all male, much smaller than their heterozygous siblings and when 
444 crosses were attempted, all three were sterile and only survived for a few days. In order 
445 to further investigate the G314D/G326E associated lethality, a complementation 
446 experiment was performed by crossing heterozygous G314D/TM3 or G326E/TM3 flies 
447 with strain #25726 from Bloomington Drosophila stock centre (genotype w[1118]; 
448 Df(3R)BSC636/TM6C, cu[1] Sb[1]) which carries a chromosomal deletion at 
449 chromosome 3R at a region that includes the GluCl gene of Drosophila. These 
450 crosses never produced any progeny not bearing the parental balancer chromosomes, 
451 indicating that indeed the lethality is linked to the deleted region that contains GluCl. 
452 Taken together, these observations suggest it is highly likely that both G314D and 
453 G326E are essentially lethal, i.e. have severe impact on channel function and viability.
454 3.5 Two-electrode voltage-clamp electrophysiology
455 3.5.1 Responses of T. urticae GluCl3 WT and GluCl3 I321T to L-glutamic acid 
456 and abamectin 
457 Two homomeric GluCl channels, consisting either solely of GluCl3 wild type (WT) 
458 subunits or GluCl3 I321T subunits, were expressed in Xenopus oocytes and the 

































































459 responsiveness of these channels was examined for L-glutamic acid and abamectin. 
460 As previously described in Mermans et al. 2017, GluCl3 WT channels generate robust 
461 responses to L-glutamic acid with rapid inward currents and fast desensitization.38 In 
462 contrast, only few of the GluCl3 I321T injected oocytes showed clear responses to L-
463 glutamic acid, with generally smaller amplitudes of currents but with the same response 
464 profile as GluCl3 WT indicating that only in a fraction of the oocytes functional GluCl3 
465 I321T receptors were formed (Fig. 2a). L-glutamic acid dose-response curves resulted 
466 in EC50s of 476.4 µM (pEC50 = 3.32 ± 0.01) and 311.3 µM (pEC50=3.51 ± 0.02) and Hill 
467 coefficients of 2.34 ± 0.14 and 2.42 ± 0.31 for GluCl3 WT and GluCl3 I321T 
468 respectively (Fig. 2d, Table 3). 
469 Next, to investigate whether both channels were activated by abamectin, 
470 injected oocytes were first tested for expression through application of EC50 L-glutamic 
471 acid. When clear inward cu rents were observed, the oocytes were subjected to an 
472 increasing concentration of abamectin (1 nM - 100 µM) with an extensive wash of 3.5 
473 min in between every concentration. Abamectin elicited inward currents through 
474 GluCl3 WT channels with a slow ons t and a very slow desensitization in comparison 
475 to L-glutamic acid responses. The same was observed for oocytes expressing GluCl3 
476 I321T, but again with a significantly (around 10-fold) smaller amplitude of currents 
477 compared to GluCl3 WT (Fig. 2b). While GluCl3 WT channels showed a clear dose 
478 dependent response, GluCl3 I321T channels seemed more insensitive to the increase 
479 of concentrations of abamectin (Fig. 2c). Therefore, an unambiguous abamectin EC50 
480 could only be calculated for GluCl3 WT (EC50 =447 nM (pEC50 = 6.32 ± 0.12)). No 
481 responses to L-glutamic acid and abamectin were observed in any oocyte injected with 
482 water alone (data not shown). 
483 Subsequently, abamectin potentiation of L-glutamic induced currents was 
484 examined in both GluCl3 channels by perfusion with 1 mM of L-glutamic acid followed 
485 by co-application of 1 mM L-glutamic acid and 100 nM abamectin. The amplitude of 
486 currents induced by the L-glutamic acid was increased by the perfusion of abamectin 
487 in wild-type GluCl3. In contrast, no clear potentiation of glutamate-induced currents 
488 was observed in oocytes expressing GluCl3 I321T (Fig. 2c). GluCl3 G326E was tested 
489 again in this study and, as in our previous study, GluCl3 G326E was not activated by 
490 abamectin even when tested at high concentrations nor could abamectin potentiate 
491 the L-glutamic acid response when co-applied (Fig. 2b&c).38 

































































492 3.5.2 Responses of T. urticae Rdls to GABA and abamectin
493 All three channels showed robust responses to the natural agonist GABA, generating 
494 rapid inward currents with a slow desensitization as long as the agonist was applied, 
495 followed by a very rapid desensitization once wash-out with NFR was started. The 
496 averaged dose-response curves for GABA were characterized by an EC50 of 15.45 µM 
497 (pEC50= 4.8 ± 0.007), 68.6 µM (pEC50=4.16 ± 0.034) and 139.8 µM (pEC50=3.85 ± 
498 0.035) for Rdl1, Rdl2 and Rdl3 respectively (Fig. 3c and Table 4). To assess the 
499 agonistic effect of abamectin, the compound was first applied alone to Rdl1, Rdl2 or 
500 Rdl3 expressed in oocytes for 3min, but the channels were not activated by abamectin 
501 (Fig. 3a). Although, when tested at high concentrations (10-100 µM), abamectin elicited 
502 very small inward currents which are negligible in amplitude compared to the GABA 
503 response (Fig. S6). To test antagonistic properties of abamectin, a cumulative 
504 exposure was used where the oocytes were pre-incubated with abamectin for 75 s 
505 followed by co-application of abamectin and GABA to ensure the maximum inhibitory 
506 effect. Perfusion of abamectin produced a dose-dependent inhibition of the GABA 
507 response for Rdl1, Rdl2 and Rdl3 regardless when EC5, EC50 or EC90 of GABA was 
508 applied (Fig. 3b-d, Fig. S5 and Table 4).
509 4 DISCUSSION 
510 Abamectin has been used extensively for spider mite control, and over the years 
511 various levels of abamectin resistance have been detected in T. urticae populations 
512 worldwide.31,33,36,45,60 The molecular mechanism underlying abamectin resistance in T. 
513 urticae have been investigated in a number of strains and both enhanced metabolic 
514 detoxification as well as target-site resistance mutations were shown to be at play. In 
515 particular, gene-expression analysis and functional characterization have pointed 
516 towards the involvement of cytochrome P450s (P450s), glutathione-S-transferases 
517 (GSTs) and uridine diphosphate (UDP) - glycosyltransferases (UGTs).36,61,62 In 
518 addition, two mutations, G314D in GluCl1 and G326E in GluCl3, were shown to be 
519 genetically linked to abamectin resistance and both G314D and G326E have been 
520 functionally validated by two-electrode voltage-clamp electrophysiology in 
521 Xenopus.14,37–40 Intriguingly, in contrast to the electrophysiological validation, 
522 introgression of mutations in GluCls in a susceptible background have revealed only a 
523 relatively weak resistance phenotype. It is therefore clear that the interplay between 
524 different receptors, their mutations and potential synergistic actions of additional 

































































525 mechanisms of resistance, is far from completely understood, and in part also the 
526 objective of this study.
527 Recently, abamectin and milbemectin (cross)-resistance mechanisms have 
528 been studied in an exceptionally wide collection of strains sampled across Europe. 
529 Aside from confirming the presence of both increased detoxification and previously 
530 described target-site mutations, this study also uncovered the presence of a potential 
531 new target-site mutation, I321T in GluCl3. Surprisingly, this mutation was only found 
532 in populations consisting of the red color morph of T. urticae.36 We further confirm in 
533 this study the presence of this mutation in two additional red T. urticae strains, TR2 
534 and MR-VL from Turkey and Belgium, respectively45,46 (Table S2) and recently, it was 
535 also detected in a Greek multi-resistant red spider mite population.41 Based on receptor 
536 sequences of green and red color morphs (Fig. S4), phylogenetic constraints do not 
537 seem to explain why this mutation only occurs in red morphs, and given the 
538 geographical origin of the strains under investigation, a single origin and spread of the 
539 mutation does not seem likely, although it is impossible to exclude. 
540 The potential relevance of I321T in abamectin resistance can first be inferred 
541 from its location in TM3, which is at the periphery of the predicted glutamate binding 
542 site and was previously reported to be involved in ivermectin binding, based on the 
543 GluCl crystal structure of C. elegans.7 In addition, an A309V mutation in P. xylostella 
544 GluCl, adjacent to I321 in T. urticae GluCl3, was also strongly associated with 
545 abamectin resistance (Fig. 1a&b).39,63 
546 We used the Xenopus system to investigate the role of the I321T mutation in 
547 the interaction of abamectin with GluCl. Compared to GluCl3 WT, functional GluCl3 
548 I321T was only successfully expressed in a limited number of oocytes, and L-glutamic 
549 acid induced currents had a significantly lower amplitude in these channels. The lack 
550 of GluCl3 I321T expression could either be due to a reduced translation of the 
551 exogenous cRNA in Xenopus oocytes or it is possible that only few of the formed 
552 receptors are functional i.e. that binding of ligands and ivermectin is compromised or 
553 that the ion channel is unable to open to its normal extend. Either way, the GluCl3 
554 I321T mutation seems to influence GluCl3 I321T expression as both GluCl3 WT and 
555 G326E showed consistent expression in Xenopus oocytes when established with the 
556 same protocol.38 
557 Nevertheless, L-glutamic acid dose-response curves could be calculated for 
558 both GluCl3 WT and GluCl3 I321T channels, and the L-glutamic acid EC50 for both 

































































559 channels differed by 1.5 fold (Table 3) only, which is in line with previous studies that 
560 examined the effect of GluCl resistance mutations using Xenopus.38,39 For both GluCl3 
561 WT and GluCl3 I321T abamectin induced currents could be observed, but, as with L-
562 glutamic acid induced currents, the amplitude of response was significantly lower for 
563 GluCl3 I321T. Further, no clear potentiation of glutamate-induced currents was 
564 observed after co-application of 1 mM L-glutamic acid and 100 nM abamectin in GluCl3 
565 I321T expressing oocytes while such increase was observed for GluCl3 WT. This 
566 subtle effect of the I321T mutation on abamectin response is in contrast to the G314D 
567 and G326E mutation, which completely abolished the agonist activity of abamectin and 
568 milbemycin A4, another macrocyclic lactone (Fig. 2b).38 But in line with the study of 
569 Wang et al., the A309V mutation in P. xylostella GluCl (corresponding to A320 and 
570 located next to I321 in T. urticae GluCl3) only resulted in 4.8 fold reduced sensitivity, 
571 while the G315E mutation (corresponding to G326E in T. urticae GluCl3) reduced the 
572 sensitivity to abamectin by 493-fold.39 This difference in effect might be explained by 
573 the interaction of these residues with macrocyclic lactones. Based on the crystal 
574 structure of C. elegans GluCl and its predicted binding to ivermectin, A320 and I321 
575 are not predicted to interact with ivermectin while G326E is predicted to have van der 
576 Waals interactions with ivermectin and is located closest to ivermectin (Fig. 1b).7 
577 However, Wang et al. 2017, predicted that P. xylostella GluCl A309V mutants might 
578 allosterically offset the functional effect of abamectin upon binding,39 and our findings 
579 suggest that this prediction also holds for the GluCl3 I321T mutation, with I321T having 
580 an effect on abamectin action, much likely by reducing channel sensitivity.
581 To further corroborate the possible likelihood of this mutation to be involved in 
582 abamectin resistance, the relative phenotypic contribution of the I321T mutation was 
583 first characterized by marker-assisted backcrossing. Two independent backcrossing 
584 experiments (BC1 and BC2) originating from two genetically different strains from 
585 distinct geographical origin were performed. Each experiment resulted in congenic 
586 lines, either homozygous for the mutant (T321/T321) or wildtype (I321/I321) GluCl3 
587 allele. For BC1, resistance ratios reached over 50-fold (Table 1) compared to the 
588 wildtype lines, but in contrast, for BC2 only low levels of abamectin resistance were 
589 observed in the mutant lines. The result of BC2 is similar to Riga et al. 2017, where 
590 only low levels of resistance were observed when either G314D in GluCl1 or G326E in 
591 GluCl3 was introgressed, indicating that a mutation in GluCl1 and GluCl3 alone was 
592 insufficient to convey resistance.51 

































































593 Marker-assisted back-crossing is expected to uncouple multiple resistance 
594 factors and reduces the proportion of donor genome with every cycle. However, if 
595 resistance genes are closely located together on the chromosome, chances to capture 
596 recombination events between adjacent genes are rare. Hence, to explain the variance 
597 between the mutant congenic lines of BC1 and BC2, one could argue that in BC1 the 
598 uncoupling of resistance genes might not have succeeded because of linkage. The 
599 fact that the mutation alone does not convey high resistance levels was also clear from 
600 the laboratory reference resistant strain MR-VL. Although this strain was fixed for the 
601 mutation, it is not highly resistant to abamectin (Table 1). Since this strain has not been 
602 selected with abamectin for more than ten years, additional factors that might 
603 contribute to resistance were probably lost, mimicking the effect of introgression. What 
604 these extra resistance factors might be is hard to resolve and could be any regulatory 
605 element of a detoxification enzyme or factors resulting in compositional changes of 
606 GluCl channels (i.e. overexpression/ underexpression of certain GluCl genes). 
607 Indeed, the differences between BC1 and BC2 and low resistance levels of MR-
608 VL point towards a lack of understanding of the role of mutations in resistance that was 
609 already previously clear from introgression work with other mutations in GluCl1 and 
610 GluCl3. These mutations also provide a weak phenotype in vivo, despite the complete 
611 lack of agonistic activity in electrophysiological studies.40 The complexity of the channel 
612 confirmation might be one of the factors involved. For example, a GluCl channel could 
613 consist of five GluCl3 encoded subunits, each carrying the I321T mutation (homomeric 
614 GluCl channel), or could be composed of GluCl subunits with or without mutation 
615 (heteromeric GluCl channel with subunits encoded by different genes) (Fig. 1c); the 
616 latter channel being likely more sensitive to abamectin. Alternatively, less-sensitive 
617 abamectin receptors could be formed through combination of GluCl and non-GluCl 
618 subunits.12 In Xue et al. 2020, it was shown that two cys‐loop ligand gated ion channel 
619 subunit genes (tetur02g11020 and tetur02g11170), were overexpressed in abamectin 
620 resistant strains. The Drosophila ortholog (CG12344) of these genes has only been 
621 poorly characterized but encode subunits of a cys-loop LGIC predicted to be most 
622 related to vertebrate glycine receptors (http://flybase.org/reports/FBgn0033558.html). 
623 Interestingly, vertebrate glycine receptors are 100‐fold less sensitive to ivermectin 
624 compared to invertebrate GluCls as they lack the TM3 glycine residue at a position 
625 corresponding to G314/G326 in T. urticae GluCl1/GluCl314,64,65 and hence heteromeric 
626 cys-loop channels consisting of GluCl and tetur02g11020/tetur02g11170 encoded 

































































627 subunits might be less sensitive to abamectin. Alternatively, less-sensitive abamectin 
628 receptors might also consist of a mix of GluCl and Rdl subunits (Fig. 1c). Such 
629 channels have been reported before,12 and homomeric Rdl channels were reported to 
630 be more than 150-fold less sensitive to ivermectin compared to GluCl channels.26 
631 Therefore, to infer whether abamectin also acts on T. urticae Rdl channels, three 
632 homomeric T. urticae Rdl channels,14 consisting either of T. urticae Rdl1, Rdl2 or Rdl3 
633 encoded subunits) were expressed using Xenopus oocytes. Abamectin alone did not 
634 invoke Rdl currents but had an antagonistic effect on all three T. urticae Rdl channels 
635 (Fig. 3 and Table 4). These observations are in line with Xu et al. 2017, in which 
636 Tetranychus Rdl channels were not activated by abamectin or ivermectin alone. 
637 However, a follow-up study of the same group showed that abamectin has an agonistic 
638 action on Tetranychus Rdl2.66,67 On the other hand, for insect and nematode Rdls, the 
639 action of ivermectin was shown to be dependent on application conditions26,68 and our 
640 results are in in agreement with previous electrophysiology studies showing that 
641 application of ivermectin alone does not have any effect on the receptor69,70 and reports 
642 showing that ivermectin is an antagonist of GABA induced Rdl currents at a GABA 
643 concentration higher than the EC50.26,68,69 This suggests that indeed, to survive high 
644 concentration of abamectin, a detoxification component or additional factor is needed 
645 to protect against additional Rdl interactions. 
646 As there was no conclusive outcome from the backcrossing experiments, we 
647 next used the CRISPR-Cas9 technology to introduce the I321T mutation in the GluCl 
648 homologue of D. melanogaster. In the past, this technology was shown to be a very 
649 useful tool to elucidate the role of a single amino acid substitution in resistance against 
650 insecticides.71 Two phenotypically homozygous fly lines bearing an I321T mutation in 
651 GluCl were generated. Toxicity bioassays with one of these lines revealed moderate 
652 abamectin resistance levels in the GluCl I321T line compared to the control. In addition, 
653 we also observed a fitness-cost (although we did not quantify) in the GluCl I321T line, 
654 with developmental time being much slower in I321T flies exposed to abamectin 
655 compared to control flies. To better interpret the effects of the GluCl I321T mutation in 
656 Drosophila, we also tried to introduce the previously documented abamectin resistance 
657 mutations, G314D in GluCl1 and G326E in GluCl3, in Drosophila GluCl. Unfortunately, 
658 no phenotypically homozygous flies could be identified at the final crossing step, and 
659 crosses between heterozygous G314D/TM3 or G326E/TM3 flies and a fly strain that 
660 had a chromosomal deletion in the GluCl region, yielded no viable progeny; strongly 

































































661 suggesting these mutations cause lethality. A lethal phenotype for flies with CRISPRed 
662 resistance mutation(s) has been reported before; see for example Bajda et al. 2017, 
663 Douris et al 2017 or Douris et al, 2020.55,71,72 Hence, Drosophila is not always a suitable 
664 species for reverse genetics with resistance mutations that were detected in other 
665 species. In the case of T. urticae and abamectin resistance, this is further complicated 
666 by the fact that there is only one GluCl gene in Drosophila while there are at least five 
667 in T. urticae.14,17 
668 Hence, ideally, one would introduce the GluCl mutations in T. urticae. As it was 
669 recently shown that CRISPR-Cas9 can be used to create gene knockouts in T. 
670 urticae,73 this type of gene-editing might soon be a feasible genetic tool for this species. 
671 Nevertheless, the lethality of the G314D/G326E mutations in Drosophila does imply 
672 that these residues have an important role in channel functioning, and is in line with a 
673 previously documented fitness cost of G314D and G326E in T. urticae.74
674 5 CONCLUSION
675 To conclude, the role of the GluCl3 I321T mutation in abamectin resistance of T. urticae 
676 was examined by in vitro functional expression and electrophysiology, backcrossing 
677 experiments and CRISPR-Cas9 gene editing in Drosophila. Based on backcross 
678 experiments, the I321T mutation alone did not always result in high abamectin 
679 resistance levels, a finding also reported for other mutations in GluCl1 and GluCl3. 
680 Genome editing in Drosophila confirmed the role of GluCl3 I321T in resistance, but 
681 again with low resistance levels. Functional analysis using Xenopus oocytes showed 
682 that the I321T mutation could reduce GluCl sensitivity to abamectin, but whether this 
683 reduction is actually due to the effect of the I321T mutation or resulting from decreased 
684 expression remains unclear. We confirm the antagonistic effect of abamectin on all 
685 three Rdls, suggesting that abamectin also acts on Rdls at high doses in T. urticae. 
686 We therefore propose that the I321T GluCl3 mutation plays a role in abamectin 
687 resistance, but only in combination with synergistic additional factors that deserve 
688 more investigation.75
689 6 ACKNOWLEDGEMENTS
690 We would like to thank professor Christos Delidakis (Institute of Molecular Biology and 
691 Biotechnology (IMBB)/University of Crete, Greece) for providing the balancer stock 
692 TM3/ TM6B, Maria Riga and Evangelia Skoufa (IMBB/University of Crete) for their help 
693 with Drosophila toxicity bioassays and Brian Gratwicke for a photograph of Xenopus 

































































694 laevis (graphical abstract). Wenxin Xue is the recipient of a doctoral grant from China 
695 Scholarship Council (CSC) and co-funded by Ghent University BOF-UGent (from 
696 03/2017 to 07/2019). This work was supported by the European Union’s Horizon 2020 
697 research and innovation program [ERC consolidator grant 772026-POLYADAPT to 
698 TVL and 773902-SuperPests to TVL and JV].
699 7 SUPORTING INFORMATION
700 Supporting information might be found in the online version of this article.
701 8 REFERENCES
702 1 Hallock KF, Sutter M, Gneezy U, Grossman PJ, Results E, Plott CR, et al., 
703 Surviving in a Toxic World, 545–547 (2012).
704 2 Wolstenholme AJ and Rogers AT, Glutamate-gated chloride channels and the 
705 mode of action of the avermectin/milbemycin anthelmintics, Parasitology 131 
706 (2005).
707 3 Shoop WL, Mrozik H and Fisher MH, Structure and activity of avermectins and 
708 milbemycins in animal health, Vet Parasitol 59:139–156 (1995).
709 4 Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, et al., 
710 Avermectins, new family of potent anthelmintic agents: Producing organism and 
711 fermentation, Antimicrob Agents Chemother 15:361–367 (1979).
712 5 Pitterna T., Chloride channel activators/new natural products: avermectins and 
713 milbemycins, Mod Crop Prot Compd, ed. by Wolfgang Kramer, Ulrich Schirmer, 
714 Peter Jeschke MW (2011).
715 6 Horenstein J, Wagner DA, Czajkowski C and Akabas MH, Protein mobility and 
716 GABA-induced conformational changes in GABA A receptor pore-lining M2 
717 segment, Nat Neurosci 4:447–485 (2001).
718 7 Hibbs RE and Gouaux E, Principles of activation and permeation in an anion-
719 selective Cys-loop receptor, Nature 474:54–60 (2011).
720 8 Ghosh R, Andersen EC, Shapiro J a, Gerke JP and Kruglyak L, Natural Variation 
721 in a Chloride Channel Subunit Confers Avermectin Resistance in C. elegans, 
722 Science (80- ) 335:574–578 (2012).
723 9 Ozoe Y, g -Aminobutyrate- and Glutamate-gated Chloride Channels as Targets 
724 of Insecticides, 1st ed., Target Recept Control Insect Pests 44, 1st ed., Elsevier 
725 Ltd. (2013).
726 10 Castle SJ, Merten P and Prabhaker N, Comparative susceptibility of Bemisia 

































































727 tabaci to imidacloprid in field- and laboratory-based bioassays, Pest Manag Sci 
728 70:1538–1546 (2014).
729 11 Prichard R, Ménez C and Lespine A, Moxidectin and the avermectins: 
730 Consanguinity but not identity, Int J Parasitol Drugs Drug Resist 2:134–153, 
731 Australian Society for Parasitology (2012).
732 12 Ludmerer SW, Warren VA, Williams BS, Zheng Y, Hunt DC, Ayer MB, et al., 
733 Ivermectin and nodulisporic acid receptors in Drosophila melanogaster contain 
734 both γ-aminobutyric acid-gated Rdl and glutamate-gated GluClα chloride 
735 channel subunits, Biochemistry 41:6548–6560 (2002).
736 13 Clark JM, Scott JG, Campos F and Bloomquist JR, Resistance to Avermectins: 
737 Extent, Mechanisms, and Management Implications, Annu Rev Entomol 40:1–
738 30 (1995).
739 14 Dermauw W, Ilias A, Riga M, Tsagkarakou A, Grbić M, Tirry L, et al., The cys-
740 loop ligand-gated ion channel gene family of Tetranychus urticae: Implications 
741 for acaricide toxicology and a novel mutation associated with abamectin 
742 resistance, Insect Biochem Mol Biol 42:455–465 (2012).
743 15 Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LHT, Schaeffer JM, 
744 et al., Cloning of an avermectin-sensitive glutamate-gated chloride channel from 
745 Caenorhabditis elegans, Nature 371:707–711 (1994).
746 16 Brown DDR, Siddiqui SZ, Kaji MD and Forrester SG, Pharmacological 
747 characterization of the Haemonchus contortus GABA-gated chloride channel, 
748 Hco-UNC-49: Modulation by macrocyclic lactone anthelmintics and a receptor 
749 for piperazine, Vet Parasitol 185:201–209, Elsevier B.V. (2012).
750 17 Knipple DC and Soderlund DM, The ligand-gated chloride channel gene family 
751 of Drosophila melanogaster, Pestic Biochem Physiol 97:140–148, Elsevier Inc. 
752 (2010).
753 18 Jones AK, Bera AN, Lees K and Sattelle DB, The cys-loop ligand-gated ion 
754 channel gene superfamily of the parasitoid wasp, Nasonia vitripennis, Heredity 
755 (Edinb) 104:247–259, Nature Publishing Group (2010).
756 19 Jones AK and Sattelle DB, The cys-loop ligand-gated ion channel gene 
757 superfamily of the red flour beetle, tribolium castaneum, BMC Genomics 8:1–16 
758 (2007).
759 20 Jones AK and Sattelle DB, The cys-loop ligand-gated ion channel superfamily of 
760 the honeybee, Apis mellifera, Invertebr Neurosci 6:123–132 (2006).

































































761 21 Ménard C, Folacci M, Brunello L, Charreton M, Collet C, Mary R, et al., Multiple 
762 combinations of RDL subunits diversify the repertoire of GABA receptors in the 
763 honey bee parasite Varroa destructor, J Biol Chem 293:19012–19024 (2018).
764 22 Kehoe J, Buldakova S, Acher F, Dent J, Bregestovski P and Bradley J, Aplysia 
765 cys-loop glutamate-gated chloride channels reveal convergent evolution of 
766 ligand specificity, J Mol Evol 69:125–141 (2009).
767 23 Beech R, Levitt N, Cambos M, Zhou S and Forrester SG, Association of ion-
768 channel genotype and macrocyclic lactone sensitivity traits in Haemonchus 
769 contortus, Mol Biochem Parasitol 171:74–80, Elsevier B.V. (2010).
770 24 Wolstenholme AJ, Glutamate-gated chloride channels, J Biol Chem 287:40232–
771 40238 (2012).
772 25 Sparks TC and Nauen R, IRAC: Mode of action classification and insecticide 
773 resistance management, Pestic Biochem Physiol 121:122–128, The Authors 
774 (2015).
775 26 Fuse T, Kita T, Nakata Y, Ozoe F and Ozoe Y, Electrophysiological 
776 characterization of ivermectin triple actions on Musca chloride channels gated 
777 by L-glutamic acid and γ-aminobutyric acid, Insect Biochem Mol Biol 77:78–86, 
778 Elsevier Ltd (2016).
779 27 Zhao X and Salgado VL, The role of GABA and glutamate receptors in 
780 susceptibility and resistance to chloride channel blocker insecticides, Pestic 
781 Biochem Physiol 97:153–160 (2010).
782 28 Fushiki S, Sugama H, Hamasaki Y and Niwa H, Functional characterization of 
783 Musca glutamate- and GABA-gated chloride channels expressed independently 
784 and coexpressed in Xenopus oocytes, Insect Mol Biol 15:773–783 (2006).
785 29 Van Leeuwen T, Vontas J, Tsagkarakou A, Dermauw W and Tirry L, Acaricide 
786 resistance mechanisms in the two-spotted spider mite Tetranychus urticae and 
787 other important Acari: A review, Insect Biochem Mol Biol 40:563–572, Elsevier 
788 Ltd (2010).
789 30 Mota-Sanchez D and Wise JC, Arthropod pesticide resistance database, 2020. 
790 http://www.pesticideresistance.org.
791 31 Xu D, He Y, Zhang Y, Xie W, Wu Q and Wang S, Status of pesticide resistance 
792 and associated mutations in the two-spotted spider mite, Tetranychus urticae, in 
793 China, Pestic Biochem Physiol 150:89–96 (2018).
794 32 Çağatay NS, Menault P, Riga M, Vontas J and Ay R, Identification and 

































































795 characterization of abamectin resistance in Tetranychus urticae Koch 
796 populations from greenhouses in Turkey, Crop Prot 112:112–117, Elsevier 
797 (2018).
798 33 Ferreira CBS, Andrade FHN, Rodrigues ARS, Siqueira HAA and Gondim MGC, 
799 Resistance in field populations of Tetranychus urticae to acaricides and 
800 characterization of the inheritance of abamectin resistance, Crop Prot 67:77–83, 
801 Elsevier Ltd (2015).
802 34 Monteiro VB, Gondim MGC, José JE, Siqueira HAA and Sousa JM, Monitoring 
803 Tetranychus urticae Koch (Acari: Tetranychidae) resistance to abamectin in 
804 vineyards in the Lower Middle São Francisco Valley, Crop Prot 69:90–96 (2015).
805 35 Khajehali J, Van Nieuwenhuyse P, Demaeght P, Tirry L, and Van Leeuwen T, 
806 Acaricide resistance and resistance mechanisms in Tetranychus urticae 
807 populations from rose greenhouses in the Netherlands, Pest Manag Sci 
808 67:1424–1433 (2011).
809 36 Xue W, Snoeck S, Njiru C, Inak E, Dermauw W and Leeuwen V, Geographical 
810 distribution and molecular insights into abamectin and milbemectin cross-
811 resistance in European field populations of Tetranychus urticae, Pest Manag Sci 
812 (2020).
813 37 Kwon DH, Yoon KS, Clark JM and Lee SH, A point mutation in a glutamate-gated 
814 chloride channel confers abamectin resistance in the two-spotted spider mite, 
815 Tetranychus urticae Koch, Insect Mol Biol 19:583–591 (2010).
816 38 Mermans C, Dermauw W, Geibel S and Van Leeuwen T, A G326E substitution 
817 in the glutamate-gated chloride channel 3 (GluCl3) of the two-spotted spider mite 
818 Tetranychus urticae abolishes the agonistic activity of macrocyclic lactones, Pest 
819 Manag Sci 73:2413–2418 (2017).
820 39 Wang X, Puinean AM, O´Reilly AO, Williamson MS, Smelt CLC, Millar NS, et al., 
821 Mutations on M3 helix of Plutella xylostella glutamate-gated chloride channel 
822 confer unequal resistance to abamectin by two different mechanisms, Insect 
823 Biochem Mol Biol 86:50–57 (2017).
824 40 Yamaguchi M, Sawa Y, Matsuda K, Ozoe F and Ozoe Y, Amino acid residues of 
825 both the extracellular and transmembrane domains influence binding of the 
826 antiparasitic agent milbemycin to Haemonchus contortus AVR-14B glutamate-
827 gated chloride channels, Biochem Biophys Res Commun 419:562–566, Elsevier 
828 Inc. (2012).

































































829 41 Papapostolou K, Riga M, Charamis J, Skoufa E, Souchlas V, Ilias A, et al., 
830 Identification and characterization of striking multiple‐insecticide resistance in a 
831 Tetranychus urticae field population from Greece, Pest Manag Sci, Wiley Online 
832 Library.
833 42 Nakata Y, Fuse T, Yamato K, Asahi M, Nakahira K, Ozoe F, et al., A single amino 
834 acid substitution in the third transmembrane region has opposite impacts on the 
835 selectivity of the parasiticides fluralaner and ivermectin for ligand-gated chloride 
836 channels, Mol Pharmacol 92:546–555 (2017).
837 43 Furutani S, Okuhara D, Hashimoto A, Ihara M, Kai K, Hayashi H, et al., An L319F 
838 mutation in transmembrane region 3 (TM3) selectively reduces sensitivity to 
839 okaramine B of the Bombyx mori L-glutamate-gated chloride channel, Biosci 
840 Biotechnol Biochem 81:1861–1867, Taylor & Francis (2017).
841 44 Bryon A, Kurlovs AH, Dermauw W, Greenhalgh R, Riga M, Grbic M, et al., 
842 Disruption of a horizontally transferred phytoene desaturase abolishes 
843 carotenoid accumulation and diapause in Tetranychus urticae, Proc Natl Acad 
844 Sci U S A 114:E5871–E5880 (2017).
845 45 İnak E, Alpkent YN, Çobanoğlu S, Dermauw W and Van Leeuwen T, Resistance 
846 incidence and presence of resistance mutations in populations of Tetranychus 
847 urticae from vegetable crops in Turkey, Exp Appl Acarol:343–360 (2019).
848 46 Van Leeuwen T, Van Pottelberge S and Tirry L, Comparative acaricide 
849 susceptibility and detoxifying enzyme activities in field-collected resistant and 
850 susceptible strains of Tetranychus urticae, Pest Manag Sci 61:499–507 (2005).
851 47 Hall TA, BioEdit: a user-friendly biological sequence alignment editor and 
852 analysis program for Windows 95/98/NT, 1999.
853 48 Van Laecke K and Degheele D, Carboxylamidases in Spodoptera exigua: 
854 properties and distribution in the larval body, Phytoparasitica 21:9–21 (1993).
855 49 Fotoukkiaii SM, Tan Z, Xue W, Wybouw N and Van Leeuwen T, Identification 
856 and characterization of new mutations in mitochondrial cytochrome b that confer 
857 resistance to bifenazate and acequinocyl in the spider mite Tetranychus urticae, 
858 Pest Manag Sci (2019).
859 50 Robertson JL and Preisler HK, Pesticide Bioassays with arthropods, CRC press 
860 (1992).
861 51 Riga M, Bajda S, Themistokleous C, Papadaki S, Palzewicz M, Dermauw W, et 
862 al., The relative contribution of target-site mutations in complex acaricide 

































































863 resistant phenotypes as assessed by marker assisted backcrossing in 
864 Tetranychus urticae, Sci Rep 7:1–12, Springer US (2017).
865 52 Port F, Chen HM, Lee T and Bullock SL, Optimized CRISPR/Cas tools for 
866 efficient germline and somatic genome engineering in Drosophila, Proc Natl 
867 Acad Sci U S A 111 (2014).
868 53 Gratz SJ, Ukken FP, Rubinstein CD, Thiede G, Donohue LK, Cummings AM, et 
869 al., Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed 
870 repair in Drosophila, Genetics 196:961–971 (2014).
871 54 Gratz SJ, Wildonger J, Harrison MM and O’Connor-Giles KM, CRISPR/Cas9-
872 mediated genome engineering and the promise of designer flies on demand, Fly 
873 (Austin) 7 (2013).
874 55 Douris V, Papapostolou KM, Ilias A, Roditakis E, Kounadi S, Riga M, et al., 
875 Investigation of the contribution of RyR target-site mutations in diamide 
876 resistance by CRISPR/Cas9 genome modification in Drosophila, Insect Biochem 
877 Mol Biol 87:127–135, Elsevi r Ltd (2017).
878 56 Abbott W, A method of computing the effectiveness of an insecticide, J Econ 
879 Entomol 18:256–267 (1925).
880 57 Sterck L, Billiau K, Abeel T, Rouzé P and Van De Peer Y, ORCAE: Online 
881 resource for community annotation of eukaryotes, Nat Methods 9:1041, Nature 
882 Publishing Group (2012).
883 58 Van Leeuwen T, Van Nieuwenhuyse P, Denholm I, Vanholme B, Tirry L, Nauen 
884 R, et al., Mitochondrial heteroplasmy and the evolution of insecticide resistance: 
885 Non-Mendelian inheritance in action, Proc Natl Acad Sci 105:5980–5985 (2008).
886 59 Rufener L, Danelli V, Bertrand D and Sager H, The novel isoxazoline 
887 ectoparasiticide lotilaner ( Credelio TM ): a non-competitive antagonist specific to 
888 invertebrates γ - aminobutyric acid-gated chloride channels ( GABACls ), Parasit 
889 Vectors:1–15, Parasites & Vectors (2017).
890 60 Piraneo TG, Bull J, Morales MA, Lavine LC, Walsh DB, and Zhu F, Molecular 
891 mechanisms of Tetranychus urticae chemical adaptation in hop fields, Sci Rep 
892 5:1–12 (2015).
893 61 Riga M, Tsakireli D, Ilias A, Morou E, Myridakis A, Stephanou EG, et al., 
894 Abamectin is metabolized by CYP392A16, a cytochrome P450 associated with 
895 high levels of acaricide resistance in Tetranychus urticae, Insect Biochem Mol 
896 Biol 46:43–53, Elsevier Ltd (2014).

































































897 62 Pavlidi N, Tseliou V, Riga M, Nauen R, Van Leeuwen T, Labrou NE, et al., 
898 Functional characterization of glutathione S-transferases associated with 
899 insecticide resistance in Tetranychus urticae, Pestic Biochem Physiol 121:53–
900 60, Elsevier Inc. (2015).
901 63 Wang X, Wang R, Yang Y, Wu S, Reilly AOO and Wu Y, A point mutation in the 
902 glutamate-gated chloride channel of Plutella xylostella is associated with 
903 resistance to abamectin, Insect Mol Biol 25:116–125 (2016).
904 64 Huang X, Chen H and Shaffer PL, Crystal Structures of Human GlyRα3 Bound 
905 to Ivermectin, Structure 25:945-950.e2, Elsevier Ltd. (2017).
906 65 Frenkel L, Muraro NI, Beltrán González AN, Marcora MS, Bernabó G, Hermann-
907 Luibl C, et al., Organization of Circadian Behavior Relies on Glycinergic 
908 Transmission, Cell Rep 19:72–85 (2017).
909 66 Xu Z, Liu Y, Wei P, Feng K, Niu J, Shen G, et al., High gama-aminobutyric acid 
910 contents involved in abamectin resistance and predation, an interesting 
911 phenomenon in spider mites, Front Physiol 8:1–11 (2017).
912 67 Xu Z, Hu Y, Hu J, Qi C, Zhang M, Xu Q, et al., The interaction between abamectin 
913 and RDL in the carmine spider mite: a target site and resistant mechanism study, 
914 Pestic Biochem Physiol 164:191–195, Elsevier (2020).
915 68 Taylor-Wells J, Senan A, Bermudez I and Jones AK, Species specific RNA A-
916 to-I editing of mosquito RDL modulates GABA potency and influences agonistic, 
917 potentiating and antagonistic actions of ivermectin, Insect Biochem Mol Biol 
918 93:1–11, Elsevier Ltd (2018).
919 69 Lees K, Musgaard M, Suwanmanee S, Buckingham SD, Biggin P and Sattelle 
920 D, Actions of agonists, fipronil and ivermectin on the predominant In vivo splice 
921 and edit variant ( RDLbd, I/V) of the Drosophila GABA receptor expressed in 
922 Xenopus laevis Oocytes, PLoS One 9 (2014).
923 70 Feng XP, Hayashi J, Beech RN and Prichard RK, Study of the nematode putative 
924 GABA type-A receptor subunits: Evidence for modulation by ivermectin, J 
925 Neurochem 83:870–878 (2002).
926 71 Douris V, Denecke S, Van Leeuwen T, Bass C, Nauen R, and Vontas J, Using 
927 CRISPR/Cas9 genome modification to understand the genetic basis of 
928 insecticide resistance: Drosophila and beyond, Pestic Biochem Physiol 
929 167:104595, Elsevier (2020).
930 72 Bajda S, Dermauw W, Panteleri R, Sugimoto N, Douris V, Tirry L, et al., A 

































































931 mutation in the PSST homologue of complex I (NADH:ubiquinone 
932 oxidoreductase) from Tetranychus urticae is associated with resistance to METI 
933 acaricides, Insect Biochem Mol Biol 80:79–90, Elsevier Ltd (2017).
934 73 Dermauw W, Jonckheere W, Riga M, Livadaras I, Vontas J and Van Leeuwen 
935 T, Targeted mutagenesis using CRISPR-Cas9 in the chelicerate herbivore 
936 Tetranychus urticae, Insect Biochem Mol Biol 120:103347, Elsevier (2020).
937 74 Bajda S, Riga M, Wybouw N, Papadaki S, Ouranou E, Fotoukkiaii SM, et al., 
938 Fitness costs of key point mutations that underlie acaricide target-site resistance 
939 in the two-spotted spider mite Tetranychus urticae, Evol Appl 11:1540–1553 
940 (2018).
941 75 Samantsidis GR, Panteleri R, Denecke S, Kounadi S, Christou I, Nauen R, et al., 
942 “What I cannot create, I do not understand”: functionally validated synergism of 
943 metabolic and target site insecticide resistance, Proceedings Biol Sci 
944 287:20200838 (2020).


































































947 Table 1. Toxicity of abamectin to adult females of backcrossed lines and their parental strains 
Strain Genotype Slope(±SE) LC50(95% CI) (mg a.i./L) RRsa,b (95%Cl)
♀SR6 x♂TR2 (BC1)
TRA_R1 321T 2.85 (±0.28) 6.00 (5.36-6.80) 44.14 (37.38-52.12)*
TRA_R2 321T 3.17 (±0.31) 8.10 (7.08-9.04) 59.51 (50.31-70.39)*
TRA_R3 321T 3.67 (±0.31) 5.85 (5.32-6.38) 42.70 (37.08-49.78)*
TRA_C1 I321 2.51 (±0.22) 0.15 (0.14-0.18) 1.13 (0.95-1.34)
Backcrossed lines
TRA_C2 I321 2.71 (±0.22) 0.13 (0.12-0.15) 0.98 (0.83-1.16)
SR6_BC1 I321 2.84 (±0.23) 0.14 (0.12-0.15) 1.00Parental strains
TR2 321T 2.52 (±0.25) 11.19 (8.57-14.50) 82.26 (69.24-97.72)*
♀SR6 x♂IT6 (BC2)
ITA_R1 321T 4.08 (±0.30) 0.42 (0.38-0.47) 1.80 (1.57-2.06)*
ITA_R2 321T 4.63 (±0.44) 0.33 (0.30-0.36) 1.39 (1.21-1.59)*
ITA_R3 321T 4.71 (±0.42) 0.34 (0.30-0.37) 1.42 (1.24-1.64)*
ITA_C1 I321 3.36 (±0.30) 0.22 (0.19-0.26) 0.94 (0.81-1.10)
ITA_C2 I321 4.82 (±0.41) 0.18 (0.15-0.21) 0.75 (0.66-0.87)*
Backcrossed lines
ITA_C3 I321 4.03 (±0.31) 0.26 (0.23-0.31) 1.11 (0.96-1.28)
SR6_BC2 I321 3.31 (±0.25) 0.24 (0.21-0.26) 1.00
Parental strains
IT6 321T 3.33 (±0.22) 24.96 (22.76-27.20) 105.5 (92.02-120.9)*
948 aThe resistance ratio (RR) compared to the susceptible strain SR6





































































953 Table 2. Log-dose probit-mortality data for abamectin tested against larvae of Drosophila genome modified strain I321T vs 
954 wild-type control (nos.Cas9). LC50 values are given in mg a.i./L. The resistance ratio (RR) is calculated by dividing the LC50 of strain 
955 I321T by the LC50 of the wild type strain nos.Cas9.
Compound Strain Slope ± SE LC50 (95% CI) (mg a.i./L) RRsa,b (95% CI)
nos.Cas9 7.32 (±1.34) 0.018 (0.014-0.020) 1
abamectin
I321T 3.70 (±0.40) 0.048 (0.039-0.055) 2.66 (2.30-3.06)*
956 aThe resistance ratio (RR) compared to the wild type strain nos.Cas9.
957 bAn asterisk (*) indicates the RR was considered significantly different from 1 based on non-overlap of 95% CI (PoloPlus LeOra Software).50
958
959 Table 3. L-glutamic acid and abamectin responses of wild- and mutant GluCls expressed in Xenopus oocytes. Data represent 
960 the mean of 8 oocytes ± SEM.
Wild-type GluCl3 I321T
EC50 (µM) pEC50 nH† EC50 (µM) pEC50 nH†
L-glutamic acid 476.4 3.32 ± 0.01 2.34 ± 0.14 311.3 3.51 ± 0.02 2.42 ± 0.31
abamectin 0.447 6.32 ± 0.12 0.97 ± 0.23 - - -








































































968 Table 4. GABA and abamectin responses of three wild-type T. urticae Rdls expressed in Xenopus oocytes. Data are the mean 
969 of 6-8 oocytes ± SEM
GABA Abamectin
n† EC50 (µM) pEC50 nH‡ n† IC50 (µM) pIC50 nH‡
Rdl1 8 15.5 4.81 ± 0.007 5.61 ± 0.56 8 0.102a 6.98 ± 0.34 -0.47 ± 0.24
6 0.058b 7.23 ± 0.17 -0.45 ± 0.11
6 0.179c 6.74 ± 1.98 -0.21 ± 0.51
Rdl2 6 68.6 4.16 ± 0.034 1.56 ± 0.16 6 0.226 6.64 ± 0.21 -1.07 ± 0.43
Rdl3 6 139.8 3.85 ± 0.035 3.36 ± 0.65 6 0.502 6.29 ± 0.35 -0.49 ± 0.18
970 †number of oocytes
971 ‡nH: Hill coefficient
972 a Co-application of GABA (EC50) and abamectin
973 b Co-application of GABA (EC5) and abamectin
974 c Co-application of GABA (EC90) and abamectin

































































975 10 FIGURES LEGENDS
976 Figure 1. Identification of an I321T mutation in GluCl3 of abamectin resistant T. 
977 urticae strains. a) Individual GluCl channel subunit, consisting of four transmembrane 
978 (TM) domains; the I321T mutation (indicated with a red star) found in abamectin 
979 resistant T. urticae is located in TM3; b) Alignment of TM3 of T. urticae GluCl1 and 
980 GluCl3 with GluCl of Drosophila melanogaster, Plutella xylostella and Caenorhabditis 
981 elegans. The I321T mutation is indicated with a red star, while the A309V mutation in 
982 P. xylostella GluCl and G314D / G326E in T. urticae GluCl1 / GluCl3, which were 
983 previously associated with abamectin resistance,14,37,38,63 are indicated with a square 
984 and triangle, respectively. C. elegans GluCl𝛼 residues that were previously shown to 
985 be involved in ivermectin binding are underlined.7 An 80% threshold was used for 
986 identity (black background) and similarity shading (grey background). Abbreviation of 
987 species names: Tu, T. urticae; Ce, C. elegans; Dm, D. melanogaster; Px, P. xylostella; 
988 c) GluCl channels consist of five GluCl subunits, which in T. urticae might be encoded 
989 by the same gene (e.g. GluCl3 carrying the I321T mutation) or can be encoded by 
990 different genes (e.g. GluCl3 I321T and GluCl1) or, as was shown for D. 
991 melanogaster,12 ivermectin receptors might be formed that consist of both GluCl and 
992 Rdl subunits.
993
994 Figure 2. L-glutamic acid and abamectin activation of GluCl3 WT and GluCl3 
995 I321T expressed in Xenopus oocytes. a): Exampl s of electrical current responses. 
996 The period of L-glutamic acid application time is indicated by the bar above the trace 
997 as well as the concentrations applied (mM); b): Examples of electrical current 
998 responses for abamectin. The period of application is indicated by the bar above the 
999 trace as well as the concentrations applied; c): Abamectin potentiation of L-glutamic 
1000 induced currents; perfusion of GluCl3 WT, GluCl3 I321T and GluCl3 G326E injected 
1001 oocytes with 1 mM of L-glutamic acid followed by co-application of 1 mM L-glutamic 
1002 acid and 100 nM abamectin; d) L-Glutamic acid dose-response curves for the 
1003 activation of wild-type and I321T GluCl3; e): Abamectin dose-response curves for the 
1004 activation of wild-type and I321T GluCl3; Error bars indicate SEM (n=8).
1005
1006 Figure 3. Antagonistic activity of abamectin on the Rdl1, Rdl2 and Rdl3 GABA 
1007 receptors expressed in Xenopus oocytes. a): A current trace when abamectin was 

































































1008 administered to Rdl1; b): Current traces from a cumulative exposure to increasing 
1009 dosage of abamectin obtained for a Xenopus oocyte expressing Rdl1. The bars 
1010 indicate the time period of co-application of GABA (15 μM) and increasing 
1011 concentrations of abamectin (1 nM - 10 µM); c): GABA dose-response curves for the 
1012 activation of Rdl1, Rdl2 or Rdl3; d): Inhibition dose-response curve measured for 
1013 abamectin obtained from oocytes expressing Rdl1, Rdl2 or Rdl3. Error bars indicate 
1014 SEM (n=6-8).

































































Figure 1. Identification of an I321T mutation in GluCl3 of abamectin resistant T. urticae strains. 
a) Individual GluCl channel subunit, consisting of four transmembrane (TM) domains; the I321T mutation 
(indicated with a red star) found in abamectin resistant T. urticae is located in TM3; b) Alignment of TM3 of 
T. urticae GluCl1 and GluCl3 with GluCl of Drosophila melanogaster, Plutella xylostella and Caenorhabditis 
elegans. The I321T mutation is indicated with a red star, while the A309V mutation in P. xylostella GluCl and 
G314D / G326E in T. urticae GluCl1 / GluCl3, which were previously associated with abamectin 
resistance,14,37,38,61 are indicated with a square and triangle, respectively. C. elegans GluClα residues that 
were previously shown to be involved in ivermectin binding are underlined.7 An 80% threshold was used for 
identity (black background) and similarity shading (grey background). Abbreviation of species names: Tu, T. 
urticae; Ce, C. elegans; Dm, D. melanogaster; Px, P. xylostella; c) GluCl channels consist of five GluCl 
subunits, which in T. urticae might be encoded by the same gene (e.g. GluCl3 carrying the I321T mutation) 
or can be encoded by different genes (e.g. GluCl3 I321T and GluCl1) or, as was shown for D. 
melanogaster,12 ivermectin receptors might be formed that consist of both GluCl and Rdl subunits. 
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Figure 2. L-glutamic acid and abamectin activation of GluCl3 WT and GluCl3 I321T expressed in 
Xenopus oocytes. a): Examples of electrical current responses. The period of L-glutamic acid application 
time is indicated by the bar above the trace as well as the concentrations applied (mM); b): Examples of 
electrical current responses for abamectin. The period of application is indicated by the bar above the trace 
as well as the concentrations applied; c): Abamectin potentiation of L-glutamic induced currents; perfusion 
of GluCl3 WT, GluCl3 I321T and GluCl3 G326E injected oocytes with 1 mM of L-glutamic acid followed by co-
application of 1 mM L-glutamic acid and 100 nM abamectin; d) L-Glutamic acid dose-response curves for the 
activation of wild-type and I321T GluCl3; e): Abamectin dose-response curves for the activation of wild-type 
and I321T GluCl3; Error bars indicate SEM (n=8). 
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Figure 3. Antagonistic activity of abam ctin on the Rdl1, Rdl2 and Rdl3 GABA receptors expressed 
in Xenopus oocytes. a): A current trace when abamectin was administered to Rdl1; b): Current traces 
from a cumulative exposure to increasing dosage of abamectin obtained for a Xenopus oocyte expressing 
Rdl1. The bars indicate the time period of co-application of GABA (15 μM) and increasing concentrations of 
abamectin (1 nM - 10 µM); c): GABA dose-response curves for the activation of Rdl1, Rdl2 or Rdl3; d): 
Inhibition dose-response curve measured for abamectin obtained from oocytes expressing Rdl1, Rdl2 or 
Rdl3. Error bars indicate SEM (n=6-8). 
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Figure S1. Drosophila GluCl target region. Nucleotide and deduced amino acid 
sequence of a 1708 bp fragment (region 3R: 19,763,457-19,765,164 of the BDGP6.22 
genome assembly) of the D. melanogaster GluCl used for homology-directed repair, 
encompassing exon 9 that contains the target aminoacid positions I307 (equivalent to 
I321 in Tu_GluCl3) and G312 (equivalent to either G314 or G326 in Tu_GluCl1 and 
Tu_GluCl3 respectively), shown in light gray shading. Intron sequences are shown in 
lowercase letters. Horizontal arrows indicate the positions of primers GluCl_generic_F 
/ GluInRV (Table S3) used for amplification and sequencing of the genome modified 
alleles.  
 

































































Figure S2. CRISPR/Cas9 strategy for generation of genome modified flies. (a): 
strategy for G314D mutation, (b): strategy for G326E mutation, (c): strategy for I321T 
mutation. All panels represent the nucleotide and deduced amino acid sequence of a 
160 bp fragment of the D. melanogaster GluCl containing part of exon 9 (uppercase) 
that bears the target positions, and adjacent intron (lowercase). Light gray area 
indicates the CRISPR/Cas9 target selected (sgRNA), while the dark gray area 
indicates the corresponding PAM (-NGG) triplet. The vertical arrow denotes the break 
point for CRISPR/Cas9-induced double stranded break. The ovals mark the non-
synonymous differences between target (wild-type) and donor (genome modified) 
sequences used to generate each mutation. Synonymous mutations incorporated for 
diagnostic purposes, as well as to avoid cleavage of the donor plasmid by the 
CRISPR/Cas9 machinery, are shown above the nucleotide sequence. Restriction sites 
abolished because of the genome modification are shown with strikethrough letters 
and the corresponding sequence is underlined. Restriction sites introduced because 
of the genome modification are shown with a dashed box and the corresponding 
sequence is also underlined. The horizontal arrow indicates the position of primer 
GluInRV (Table S3) used for sequencing of the genome modified alleles. 
 

































































Figure S3. Screening for genome-modified I321T flies. (a): PCR screening 
following digestion with ClaI of template DNA from pools of G1 flies derived from 
different G0 (injected) individuals using a specific primer combination (GluCl_generic_F 
/ GluCl_specific_R, Table S3) that provides a diagnostic 429 bp band for the I321T 
mutation. (b): Screening of individual balanced G2 flies for I321T alleles using the 
specific primer combination (GluCl_generic_F / GluCl_specific_R, Table S3); several 
positive crosses are visible. m: MW marker -: nos.Cas9 DNA (negative control), +: 
donor plasmid template (positive control). (c): Sequencing of the relevant GluCl region 
in homozygous genome modified flies. Vertical arrows indicate modified nucleotides. 
The boxed ACC triplet encodes I321T.

































































Figure S4. Nucleotide alignment of the TM3 region of GluCl3 of red morph T. 
urticae strains investigated in this study and a green morph T. urticae strain 
(London). The mutation I321T (ATT-> ACT) characterized in this study in six T. urticae 
strains (IT1, IT5 IT6, ES1, MR-VL and TR2) is indicated with a red arrow and a red 
font. The V327G (GTC-> GCC) and L329F (CTT-> TTT) mutation found in ES1 in our 
previous study is indicated with a blue arrow and blue font.36 The London (green font) 
abamectin susceptible strain originated from a wild-collected T. urticae population from 
the Vineland region (Ontario, Canada) and its TM3 GluCl3 sequence was downloaded 
from the ORCAE website 
(http://bioinformatics.psb.ugent.be/webtools/bogas/overview/Tetur) with accession 
number tetur10g03090).14,73 An 90% threshold was used for identity (black background) 
and similarity shading (grey background). 

































































Figure S5. Dose-response regression curve measured for abamectin obtained 
from oocytes expressing Rdl1 and tested with the EC5, EC50 or EC90 of GABA. 
Error bars indicate SEM (n=8).
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Table S1. T. urticae populations used in this study
Strain DOCa Origin Host plant Reference
IT1 06/2017 Granieri, Italy Carnation
IT5 05/2018 Granieri, Italy Carnation
IT6 05/2018 Vittoria, Italy Gerbera
ES1 05/2017 Sevilla, Spain Strawberry
Xue et al. 2020
MR-VL 2005 Gent, Belgium poplar cuttings, beans or ornamentals
Van Leeuwen et al., 2005 
(fenbutatin oxide selection line)
TR2 11/2017 Mersin, Turkey Zucchini İnak et al., 2019
SR6 2017 Italy Tomato This Study
aDate of collection
Table S2. GluCl1/2/3/4/5 TM3 and Rdl1/2/3 TM2/TM3 region genotypes and abamectin resistance in the surveyed T. urticae 
populations 
AbamectinStrain GluCls Rdls
Slope(±SE) LC50s (95% CI)/ mg L-1 RRsa,b (95%Cl)
IT1 I321T in GluCl3 - 3.31 (±0.32) 14.64 (12.08-17.12) 61.00 (50.33-71.33)*
IT5 I321T in GluCl3 - 4.28 (±0.13) 14.26 (12.45-16.15) 59.42 (51.88-67.29)*
IT6 I321T in GluCl3 - 3.33 (±0.22) 24.96 (22.76-27.20) 104.0 (94.8-113.3)*
ES1 I321T/V327G/L329F in GluCl3 - 2.53 (±0.18) 78.59 (67.63-90.84) 327.5 (281.8-378.5)*
MR-VL I321T in GluCl3 - 3.78 (±0.28) 1.79 (1.66-2.12) 7.46 (6.92-8.83)*
TR2 I321T in GluCl3 - 2.52 (±0.25) 11.19 (8.57-14.50) 46.63 (35.71-55.77)*
SR6 - - 3.31 (±0.25) 0.24 (0.21-0.26) 1.00
aResistance Ratios compared to the susceptible strain SR6
bAn asterisk (*) indicates the RR was considered significantly different from 1 based on non-overlap of 95% CI (PoloPlus LeOra Software).50
































































Table S3. Primers used in this study 



















survey of TM2/TM3 region of Rdls
sgRNA sense CTTCGAAGGCCATCGATGTGTGGAC 
sgRNA antisense AAACGTCCACACATCGATGGCCTTC sgRNA
GluExFw TGGATGGCATTTCTCTGTACCT
GluExRv GCAAGGAACCGAACAAATCGT Genomic region amplification / sequencing
GluInFw ACCTAACCCCTTTTGCAGGT
GluInRv ATGCATAGTTCACCAGGGCG Genomic region sequencing
GluCl_generic_F TCAGCATTAAAGAACCAGCGT
GluCl_specific_R CACGCCTGTCCAGACGTCGG Sequencing, allele screening
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